Skip to main content

Jorge E Lascano, MD

Critical Care Specialist

Photo of Jorge E Lascano

My Locations

Active clinical trials

KB407-02

This study will evaluate safety and tolerability of ascending doses of nebulized KB407 in adults with cystic fibrosis.

Investigator
Jorge E Lascano
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
ELEVAATE OLE

Phase 2 open label extension study to evaluate INBRX-101 in adults with AATD emphysema

Investigator
Jorge E Lascano
Status
Accepting Candidates
Ages
18 Years - 80 Years
Sexes
All
INBRX101-201

Phase 2 study to compare SAR447537 (INBRX-101) to plasma derived A1PI therapy in adults with AATD emphysema

Investigator
Jorge E Lascano
Status
Accepting Candidates
Ages
18 Years - 80 Years
Sexes
All
View all of Dr. Lascano's active clinical trials

My research

Top areas of exploration

  • alpha 1-Antitrypsin Deficiency , 9 publications
  • Pulmonary Disease, Chronic Obstructive , 8 publications
  • alpha 1-Antitrypsin , 7 publications
  • Cystic Fibrosis , 5 publications

Research activity

44 publications

354 citations

Why is this important?
View more of Jorge Lascano's research activity

Accepted insurances

Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.

See all insurances

My areas of focus

Stories and news

View more stories related to Jorge Lascano